Penumbra, Inc. (PEN) Cash Flow Statement

The gap between net income and operating cash flow has been consistently positive, indicating that earnings are backed by cash generation. However, the variability in OCF/NI, from 0.99 in 2025Q2 to 2.67 in 2026Q1, suggests that working capital swings and non-cash items like stock-based compensation can distort quarterly comparisons. Investors should monitor whether the recent EPS miss reflects a deterioration in cash conversion quality or merely timing effects.

The FCF margin has been volatile, with a peak of 19.6% in 2026Q1 and a trough of 6.0% in 2024Q2. The recent decline is driven by a combination of lower operating cash flow and higher capital expenditures, which increased to $13.5M in 2026Q2 from $5.4M in 2024Q4. This suggests that the company is investing more heavily in growth initiatives, potentially in the Thunderbolt system, which may pressure near-term FCF but could support long-term expansion.

The rise in capex, from $5.4M in 2024Q4 to $13.5M in 2026Q2, suggests that Penumbra is investing in manufacturing capacity or new product launches, likely related to the computer-assisted aspiration systems. This increased capital intensity may be necessary to support the company's growth strategy, but it also reduces free cash flow in the near term. The sustainability of this investment will depend on whether it translates into higher revenue growth and market share gains.

The large positive working capital contribution in 2026Q1 was likely due to favorable collections or payables timing, while the negative swing in 2026Q2 suggests an increase in inventory or receivables. This volatility may be related to the launch of new products and consignment arrangements, which can create shadow inventory. Investors should monitor whether these swings indicate a structural change in working capital efficiency or just seasonal fluctuations.

The company appears to be reinvesting all cash flow back into the business, consistent with its growth-oriented strategy. The one-time buyback in 2024Q3 may have been opportunistic, but the overall lack of capital returns suggests management is prioritizing organic growth and R&D. This approach could be value-accretive if the investments generate strong returns, but it also means shareholders rely entirely on earnings growth for returns.

The cumulative gap of $281.2M between operating cash flow and net income is largely attributable to non-cash charges like depreciation and stock-based compensation, which are added back to net income. This suggests that reported earnings understate the company's cash-generating ability, which is a positive sign for valuation. However, the recent EPS miss and decelerating growth may temper the market's enthusiasm despite this cash strength.